000 04620cam a2200529 i 4500
005 20250919005403.0
008 150810t20142014vtu b 001 0 eng
020 _a9781472423573 (hardback : alk. paper)
_cRM390.00
020 _a1472423577 (hardback : alk. paper)
020 _z9781472423580 (ebk - PDF)
020 _z9781472423597 (ebk - ePub)
020 _a1472423593 (electronic bk.)
020 _a1472423585 (electronic bk.)
039 9 _a201511241057
_bzainol
_c201510291630
_dfida
_c201510291629
_dfida
_y08-10-2015
_zfashihah
040 _aUKM
_erda
090 _aQV21.B583p 2014 9
090 _aQV21
_b.B583p 2014 9
100 1 _aBicudo, Edison,
_eauthor.
245 1 0 _aPharmaceutical research, democracy and conspiracy :
_binternational clinical trials in local medical institutions /
_cEdison Bicudo, King's College, London, UK.
264 1 _aFarnham, Surrey, England :
_bGower,
_c[2014]
264 4 _c@2014
300 _axvi, 175 pages ;
_c25 cm
336 _atext
_2rdacontent
337 _aunmediated
_2rdamedia
338 _avolume
_2rdacarrier
490 0 _aGower applied research
504 _aIncludes bibliographical references (pages 165-171) and index.
505 0 _aMachine generated contents note: 0.1.What is a Global Clinical Trial? -- 0.2.What is a CRO? -- 0.3.Multicentre Trials and Social Actions -- 0.4.Aims -- 0.5.Methods, Fieldwork, and Limitations -- 0.6.The Structure of the Book -- 0.7.What is Schrodinger's Cat? -- pt. ONE GLOBAL TRIALS IN MEDICAL INSTITUTIONS -- ch. 1 Infrastructure: The Indirect Privatization of Hospitals -- 1.1.National Regulatory Renewals -- 1.2.The Global Space of Multinational CROs -- 1.3.What are Feasibility Studies? -- 1.4.Criteria to Include or Exclude Sites -- 1.5.What is'n'? -- 1.6.Multicentre Trials and'Systems of Objects' -- 1.7.Multicentre Trials and'Systems of Actions' -- 1.8.Recruitment Partnerships -- 1.9.The Indirect Privatization of Hospitals -- ch. 2 Payments: Global Trials and Local Agreements -- 2.1.Institutional Mechanisms -- 2.2.What is a Research Contract? -- 2.3.What is a Study's Budget? -- 2.4.Hybrid Work -- 2.5.The Dark Side of Research Contracts --
505 0 _aContents note continued: 2.6.Global Trials and Local Agreements -- ch. 3 Care: The Global Need for Global Trials -- 3.1.Who are Key Opinion Leaders? -- 3.2.What is a Therapeutic Trial? -- 3.3.Clinical Trials and Medical Decisions -- 3.4.Criteria to Include or Exclude People -- 3.5.Clinical Agreements -- 3.6.Therapy and Care -- 3.7.Global Trials and'Disposable Income' -- 3.8.The Global Need for Global Trials -- pt. TWO GLOBAL TRIALS IN THE GEOGRAPHICAL SPACE -- ch. 4 Communication: The Collective Design of Clinical Protocols -- 4.1.Research Sites and'Communicational Densities' -- 4.2.Clinical Trials in Urban Contexts -- 4.3.The Medical Community -- 4.4.Where do Research Subjects Really Come From? -- 4.5.Global Trials Embedded in Local Contexts -- 4.6.What is a Protocol's Amendment? -- 4.7.The Collective Design of Clinical Protocols -- ch. 5 Globalization: Clinical Trials and International Hierarchies -- 5.1.What are Rescue Countries? --
505 0 _aContents note continued: 5.2.Criteria to Include or Exclude Countries -- 5.3.What is Competitive Recruitment? -- 5.4.Clinical Trials and International Hierarchies -- ch. 6 Hope: The Symbolic Dimension of Global Trials -- 6.1.The'Symbolic Efficacy' of Medicines -- 6.2.The Limits of Medicine -- 6.3.How Trustable are Clinical Trials? -- 6.4.Global Trials for Hopeful Patients -- 6.5.Global Trials for Hopeless Hospitals -- 6.6.The Symbolic Dimension of Global Trials -- Conclusion -- Intermediary Groups and Sociology -- Towards a General Theory of Communicative Action -- Global Trials and Institutionalization.
650 2 _aDrugs
_xTesting
_xGovernment policy.
650 2 _aClinical trials
_xMoral and ethical aspects.
650 2 _aPharmaceutical industry
_xMoral and ethical aspects.
650 7 _aClinical trials
_xMoral and ethical aspects.
_2fast
_0(OCoLC)fst00864436
650 7 _aDrugs
_xTesting
_xGovernment policy.
_2fast
_0(OCoLC)fst00898943
650 7 _aPharmaceutical industry
_xMoral and ethical aspects.
_2fast
_0(OCoLC)fst01060163
650 2 _aClinical Trials as Topic
_xethics.
650 2 _aDrug Industry
_xethics.
907 _a.b16190397
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV21.B583p 2014 9
914 _avtls003591420
990 _azr
991 _aFakulti Farmasi, KKL
998 _ad
_b2015-10-08
_cm
_da
_feng
_gvtu
_y0
_z.b16190397
999 _c596810
_d596810